2011 BIO International Convention in Washington, D.C., June 27-30

April 18, 2011

Washington, D.C.

The BIO International Convention is the largest global event for the biotechnology industry, providing insights on major scientific, business, and legal trends affecting the biotechnology and pharmaceutical industries.

Please contact us if you would like to schedule a meeting at the convention. Marshall, Gerstein & Borun is at Exhibit Booth 2478 and speaking during the following sessions:

Biomarkers Track - IP Issues Affecting Biomarker-Based Diagnostics, June 27, 2011 at 3:45 p.m. in Room 152A

David A. Gass and an international panel of patent professionals will discuss challenges for securing IP protection for biomarker diagnostics. Panelists will discuss:

  • How the Supreme Court's decision on "business method patents" in Bilski v. Kappos impacts biomarker diagnostics
  • Important cases before the Federal Circuit, such as Myriad (patent eligibility of "genes" and diagnostic methods), Prometheus and Classen (patent eligibility of diagnostic inventions with a treatment component)
  • Territoriality and joint infringement considerations
  • Perspectives on these issues before the US PTO and EPO

Biotech Patenting and Tech Transfer Track - Innovative Collaborations: Successful Deal Structures for Non-Profit/For-Profit Collaborations, June 30, 2011 at 8:30 a.m. in Room 151A

Pamela L. Cox will be joined by representatives of senior leadership at The Procter & Gamble Company, Novozymes, Mayo Clinic and Cambridge Enterprise at the University of Cambridge who will share their insights on what deal structures support successful industry collaboration with non-profits. The panel will:

  • Provide examples of productive collaborations and discuss the elements of those deals that contributed to their success
  • Cover agreement terms that might be used to implement those elements in your collaborations
  • Reflect on a few cautionary tales of failed collaborations, the warning signs and how to structure and draft your collaboration for a better outcome